• Explore /
  • Poster
  • / Post radical prostatectomy (RP) PSA outcomes following 6 vs 18 months of perioperative androgen deprivation therapy (ADT) in men with localized high risk prostate cancer (LHRPC): Results of Part 2 of a randomized phase 2 trial.

Post radical prostatectomy (RP) PSA outcomes following 6 vs 18 months of perioperative androgen deprivation therapy (ADT) in men with localized high risk prostate cancer (LHRPC): Results of Part 2 of a randomized phase 2 trial.

Abstract Poster

Authors

null

Rana R. McKay

University of California San Diego, La Jolla, CA

Rana R. McKay , Wanling Xie , Xiaoyu Yang , Dana E. Rathkopf , Vincent Paul Laudone , Glenn Bubley , David Johnson Einstein , Peter Chang , Andrew Wagner , Christopher J. Kane , J. Kellogg Parsons , Mark A. Preston , Kerry L. Kilbridge , Steven Lee Chang , Atish Dipankar Choudhury , Quoc-Dien Trinh , Mark Pomerantz , Adam S. Kibel , Mary Ellen Taplin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT02903368

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5095)

DOI

10.1200/JCO.2023.41.16_suppl.5095

Abstract #

5095

Poster Bd #

189

Abstract Disclosures

Similar Posters

First Author: Nicholas George Nickols

First Author: John Nikitas

First Author: Yao Zhu

First Author: Marc Dall'era